Related Experiment Video
Updated: Jun 26, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Lupus update: perspective and clinical pearls.
1Director, Patient Care and Translational Research, Lupus Center of Excellence, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA 15261, USA. sxm6+@pitt.edu
Cleveland Clinic Journal of Medicine
|February 4, 2009
Summary
Systemic lupus erythematosus (SLE) survival has improved, but patients face increased risks of cancer, cardiovascular disease, and osteoporosis. New therapies are emerging due to better understanding of lupus immunology.
Area of Science:
- Immunology
- Rheumatology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with complex immunological underpinnings.
- Historically, SLE carried a poor prognosis, but significant advancements have improved patient survival rates over the past 50 years.
Purpose of the Study:
- To highlight the evolving landscape of SLE patient outcomes.
- To identify the increased long-term health risks associated with improved SLE survival.
- To underscore the potential for novel therapeutic strategies driven by immunological insights.
Main Methods:
- This is a review and commentary based on current understanding of SLE.
- Analysis of epidemiological trends in SLE patient survival and comorbidity.
- Synthesis of recent research on SLE immunological mechanisms.
Main Results:
- Patients with SLE now exhibit markedly better survival rates compared to 50 years ago.
- Despite improved survival, SLE patients experience a higher incidence of cancer, cardiovascular disease, and osteoporosis at earlier ages.
- Advances in understanding SLE's immunological basis are paving the way for new treatment options.
Conclusions:
- Improved SLE survival is a significant clinical achievement.
- Proactive management of comorbidities like cancer, cardiovascular disease, and osteoporosis is crucial for SLE patients.
- Further research into SLE immunology promises to yield innovative and effective therapies.
More Related Videos
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:25Pericarditis IV: Nursing Management
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.